Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does the presence of a BRCA 1/2 mutation affect your recommendation for post-mastectomy RT in patients with pT1-2, N0 disease?
Answer from: Radiation Oncologist at Community Practice
It doesn’t influence RT decision.
Sign In
or
Register
to read more
11230
Related Questions
Does delay to the time of lumpectomy impact your decision to omit radiation?
When using surface image-guidance for breast radiation, how do you accommodate for changes in anatomy?
Do you recommend high ozonated oil for radiation dermatitis?
Would you consider omitting adjuvant radiation in a very elderly patient with a small triple negative breast cancer?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
How would you approach a patient with a 12 mm recurrence of the left implant-based breast reconstruction 17 years after her initial diagnosis?
Is DCISionRT appropriate for multifocal DCIS?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?
How would you manage an isolated nodal recurrence of breast cancer in a patient with a prior history of mantle-field radiation?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?